NarváezAAgudeloCSaldarriagaC, et al.Risk factors associated with the onset of atrial fibrillation in patients with sepsis and septic shock in intensive care units. J Intensive Care Med [Internet]2026 [cited 2026 Jan 30]; Available from: https://journals.sagepub.com/doi/10.1177/08850666251412802
2.
XuWLiJJuJ, et al.The beta1-adrenergic receptor in the heart. Cell Death Discov. 2025;12(1):46.
3.
WieruszewskiEDJonesGMSamarinMJKimmonsLA. Predictors of dysrhythmias with norepinephrine use in septic shock. J Crit Care. 2021;61:133‐137.
4.
VincentJ-LMorenoRTakalaJ, et al.The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22(7):707‐710.
5.
EvansLRhodesAAlhazzaniW, et al.Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063‐e1143.
6.
ScheerenTWLBakkerJDe BackerD, et al.Current use of vasopressors in septic shock. Ann Intensive Care. 2019;9(1):20.
7.
SachaGLLamSWDuggalA, et al.Predictors of response to fixed-dose vasopressin in adult patients with septic shock. Ann Intensive Care. 2018;8(1):35.
8.
JozwiakMCousinVLDe BackerD, et al.Vasopressin use across shock states: International insights from an international ESICM-endorsed survey: The PRESS survey. Crit Care. 2025;29(1):273.
9.
McIntyreWFUmKJAlhazzaniW, et al.Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: A systematic review and meta-analysis. JAMA. 2018;319(18):1889.
10.
RussellJAWalleyKRSingerJ, et al.Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877‐887.
11.
SachaGLBauerSR. Optimizing vasopressin use and initiation timing in septic shock. CHEST. 2023;164(5):1216‐1227.
